{"transactions":[{"id":697334,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-04T20:55:40.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-26-025694","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926025694/rdgdoc.xml","form_type":"4"}},{"id":734287,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2026-06-17T21:08:00.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested on a quarterly basis over 12 months from the date of grant until fully vested on February 7, 2023."}],"balance_after":0,"derivative":{"exercise_price":3.78,"exercise_date":"2023-02-07","expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-021000","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926021000/rdgdoc.xml","form_type":"4"}},{"id":734286,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-17T21:08:00.000Z","date":"2026-06-17","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":32.4759,"value":1623795.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $32.10 to $32.71. The price reported above reflects the weighted average sales price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-26-021000","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926021000/rdgdoc.xml","form_type":"4"}},{"id":734285,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-17T21:08:00.000Z","date":"2026-06-17","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":3.78,"value":189000.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-26-021000","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926021000/rdgdoc.xml","form_type":"4"}},{"id":939282,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-14T23:08:18.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in one annual installment beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":178086,"derivative":{"underlying":"Common Stock","underlying_shares":7757},"source":{"system":"sec-edgar","filing":"0001437749-26-001298","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926001298/rdgdoc.xml","form_type":"4"}},{"id":939281,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-14T23:08:18.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":12196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 12, 2027."}],"balance_after":170329,"derivative":{"exercise_price":15.47,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":12196},"source":{"system":"sec-edgar","filing":"0001437749-26-001298","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774926001298/rdgdoc.xml","form_type":"4"}},{"id":1310956,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-06T21:23:42.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest equally on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 3, 2026."}],"balance_after":25000,"derivative":{"exercise_price":13,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-25-000468","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774925000468/rdgdoc.xml","form_type":"4"}},{"id":1641169,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-15T21:19:59.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025."}],"balance_after":133133,"derivative":{"exercise_price":4.42,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-24-004367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000143774924004367/rdgdoc.xml","form_type":"4"}},{"id":1974493,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-03T21:10:15.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested on February 20, 2024."}],"balance_after":103133,"derivative":{"exercise_price":3.47,"expiration_date":"2033-02-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-006673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000149315223006673/ownership.xml","form_type":"4"}},{"id":2369223,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-02-28T21:39:30.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested on February 7, 2023."}],"balance_after":78133,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-005622","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000149315222005622/ownership.xml","form_type":"4"}},{"id":2727606,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":26683,"kind":"person","name":"Adams Jennifer McKie","position":1,"cik":"0001851440","reported_name":"Adams Jennifer McKie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-05-05T20:15:44.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":28133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on an annual basis over three years from the date of grant until fully vested and exercisable on May 3, 2024."}],"balance_after":28133,"derivative":{"exercise_price":8.61,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":28133},"source":{"system":"sec-edgar","filing":"0001493152-21-010521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851440/000149315221010521/ownership.xml","form_type":"4"}}]}